Phase III Trial Comparing Ribociclib with Chemotherapy in High Stage Breast Cancer
A phase III trial, sponsored by the National Cancer Institute, is currently evaluating the efficacy of hormone therapy combined with ribociclib against chemotherapy followed by hormone therapy in patients diagnosed with high anatomic stage breast cancer characterized by low recurrence risk.